Conversion from Twice-Daily to Once-Daily Tacrolimus in Stable Lung Transplant Recipients: Short-Term Effects on Renal Function and Diabetic Parameters
Prolonged-release formulation of tacrolimus (TAC) provides more convenient once-daily dosing and may improve patient adherence. We investigated the effects of conversion from twice-daily (TDT) to once-daily (ODT) TAC on renal function and diabetic parameters in a large cohort of stable lung transplant (LTx) recipients.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: L. Godinas, L. Hulst, R. Vos, B.M. Vanaudenaerde, S.E. Verleden, D.E. Van Raemdonck, A.P. Neyrinck, G.M. Verleden Source Type: research
More News: Cardiology | Diabetes | Endocrinology | Heart | Heart Transplant | Lung Transplant | Prograf | Tacrolimus | Transplant Surgery | Transplants